Get my own profile
Public access
View all4 articles
1 article
available
not available
Based on funding mandates
Co-authors
- Harm-Anton KlokVerified email at epfl.ch
- Anseth KristiUniversity of Colorado and the BioFrontiers InstituteVerified email at colorado.edu
- Jason Silver, MD PhDUniversity of Washington MedicineVerified email at uw.edu
- Patrick TheatoKarlsruhe Institute of Technology (KIT)Verified email at kit.edu
- Tobin BrownMosaic BiosciencesVerified email at mosaicbio.com
- F. Max YavittPostdoctoral Fellow in the CReaTE Group, University of OtagoVerified email at otago.ac.nz
- Tova Ceccato (Christensen)University of Colorado, BoulderVerified email at colorado.edu
- Frank DelRioSandia National LaboratoriesVerified email at sandia.gov
- Leslie LeinwandDistinguished Professor of Molecular, Cellular and Developmental Biology and Chief Scientific Officer of the BioFrontiers Institute, University of Colorado BoulderVerified email at colorado.edu
- Christopher BowmanUniversity of coloradoVerified email at colorado.edu
- Ian A. MarozasUniversity of Colorado, BoulderVerified email at colorado.edu
- Brady WorrellUniversity of DenverVerified email at du.edu
- Michael BlatchleySyracuse UniversityVerified email at syr.edu
- Tze-Ling ChangUniversity of Colorado, BoulderVerified email at colorado.edu
- Nathaniel SkillinUniversity of Colorado BoulderVerified email at cuanschutz.edu
- Laura MacdougallUniversity of Colorado BoulderVerified email at colorado.edu
- Varsha V. RaoUniversity of Colorado BoulderVerified email at colorado.edu
- Chi ZhangMIT Media Lab, McGovern Institute for Brain ResearchVerified email at mit.edu
- Chih-Chieh (Jay) YuPostdoc at RIKEN, JapanVerified email at riken.jp
- Ed BoydenMIT, HHMIVerified email at mit.edu
Follow
Kemal Arda Günay
Vaccine MFG Tech. Lead at AC Immune - Prev. Postdoc at CU Boulder - EPFL Alumni
Verified email at acimmune.com